Model Integration and Configuration for Metabolic and

Data Characteristics in This Category

Pharmacovigilance data in the metabolic and endocrine disease domain primarily originates from clinical trial reports, real-world evidence (RWE), post-market surveillance systems (e.g., FDA Adverse Event Reporting System, FAERS), and academic literature. This data exists in both structured (e.g., database records) and unstructured forms (e.g., free-text case reports, handwritten physician notes, patient feedback). Update frequency is high; clinical trial data is released periodically as trials progress, and post-market surveillance data continuously flows in. Document structures are diverse, including Case Report Forms (CRF), medical reports, and medical records. These documents contain extensive medical terminology, abbreviations, and dosage units (e.g., mg/kg, IU). Common fields include patient demographics, diagnoses, medication history, adverse event names, onset times, severity, and outcomes, with a particular focus on changes in physiological indicators such as blood glucose, blood pressure, and blood lipids.

Constraints Imposed by These Characteristics on Model Integration and Configuration

The highly specialized and diverse nature of metabolic and endocrine data places specific demands on model integration and configuration. First, the data contains a large volume of medical terminology and abbreviations. This requires models with robust entity recognition and relation extraction capabilities. Configuration must include the integration of specialized dictionaries and ontologies. Second, unstructured data, such as free-text descriptions in case reports, constitutes a significant portion. This requires models to handle long text inputs and accurately extract key information, directly influencing the maxContext parameter setting. Third, the real-time requirements for adverse event reporting dictate strict control over data synchronization and model inference latency, directly impacting batch_size and concurrent request numbers. Finally, the diversity of dosage and units for physiological indicators means models must understand and standardize this information. For example, blood glucose values in different units need unified processing. This may require specific configuration or data cleaning during the model's preprocessing stage.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`maxContext`	`8192 tokens`	Pharmacovigilance reports often contain detailed medical histories and medication records. A longer context window prevents information loss.
`temperature`	`0.3–0.5`	Pharmacovigilance analysis prioritizes accuracy and consistency. Lower temperature values reduce the randomness of model output.
`top_p`	`0.7–0.9`	Balances output diversity with accuracy, preventing repetitive model responses while ensuring reliability of results.
`Chunk size` (Segment Length)	`500–800 characters`	Ensures each segment contains sufficient contextual information while preventing individual segments from being too long and diluting key information.
`Similarity threshold` (Similarity Threshold)	`0.75–0.85`	Descriptions of metabolic and endocrine adverse reactions have a certain standardization. A higher threshold enables more precise matching of relevant knowledge.
`Rerank result count` (Reranked Results Count)	`Top 5`	After initial retrieval, the most relevant results are re-ranked for refinement, improving the quality of the final answer.

Three Common Mistakes

Model calls result in a Bad Request: 400 error, with the message context window exceeded. This typically occurs when the maxContext parameter configured for the model is too small to accommodate long pharmacovigilance reports or multi-turn conversation history.
Multiple model calls are set up in a workflow, but subsequent models fail to access the complete conversation history. This happens because the number of turns to retain chat history configuration is inconsistent across different model nodes in the workflow, leading to information truncation during transfer.
Model output for adverse event names or dosage units is inconsistent. For example, mg/dL and mmol/L coexist without conversion. This indicates that data standardization requirements were not adequately considered during model integration, or the prompt did not explicitly request a unified output format.

How to Confirm Correct Configuration

Select different types of pharmacovigilance reports from this category and perform multiple calls in the model testing interface. Check the accuracy and completeness of the model's output, especially its identification of key entities (e.g., drugs, adverse events, dosages).
Simulate multi-turn conversation scenarios, such as asking for detailed information about an adverse event. Observe whether the model correctly understands and utilizes historical conversation context to ensure the number of turns to retain chat history is appropriately configured.
Perform a sample check of physiological indicator data returned by the model. Verify if dosage units are consistent, if values are within a reasonable range, and compare them with original data to confirm that data standardization processing is effective.

The values provided are common starting points and should be measured against specific samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.